Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|---|---|
BT-20 | Palbociclib | 0.1 | CDK4/6 | Cell cycle | 0.3557 | 0.03619 |
BT-20 | AZD7762 | 0.1 | CHK1/2 | Cell cycle | 1.1714 | 0.04490 |
BT-20 | Abemaciclib | 1.0 | CDK4/6 | Cell cycle | 0.2233 | 0.00560 |
BT-20 | Palbociclib | 0.031623 | CDK4/6 | Cell cycle | 0.5715 | 0.01511 |
BT-20 | AZD7762 | 0.001 | CHK1/2 | Cell cycle | 1.1198 | -0.00253 |
BT-20 | AZD7762 | 0.031623 | CHK1/2 | Cell cycle | 1.2229 | 0.01175 |
BT-20 | Abemaciclib | 0.01 | CDK4/6 | Cell cycle | 0.7022 | -0.00034 |
BT-20 | Abemaciclib | 0.31623 | CDK4/6 | Cell cycle | 0.2635 | 0.00452 |
BT-20 | Palbociclib | 0.00031623 | CDK4/6 | Cell cycle | 1.0619 | -0.00163 |
BT-20 | Palbociclib | 0.01 | CDK4/6 | Cell cycle | 0.8023 | 0.00566 |
BT-20 | Palbociclib | 1.0 | CDK4/6 | Cell cycle | 0.2044 | 0.04646 |
BT-20 | Palbociclib | 3.1623 | CDK4/6 | Cell cycle | 0.1624 | 0.05010 |
BT-20 | AZD7762 | 0.0031623 | CHK1/2 | Cell cycle | 1.2431 | -0.00726 |
BT-20 | AZD7762 | 0.01 | CHK1/2 | Cell cycle | 1.2200 | 0.00225 |
BT-20 | Abemaciclib | 0.001 | CDK4/6 | Cell cycle | 0.9370 | -0.00149 |
BT-20 | Abemaciclib | 0.0031623 | CDK4/6 | Cell cycle | 0.8833 | -0.00527 |
BT-20 | Abemaciclib | 0.031623 | CDK4/6 | Cell cycle | 0.4936 | -0.00426 |
BT-20 | Abemaciclib | 0.1 | CDK4/6 | Cell cycle | 0.3565 | 0.00950 |
BT-20 | Abemaciclib | 3.1623 | CDK4/6 | Cell cycle | 0.1622 | 0.01068 |
BT-20 | Abemaciclib | 10.0 | CDK4/6 | Cell cycle | -0.2160 | 0.37259 |
BT-20 | Palbociclib | 0.001 | CDK4/6 | Cell cycle | 1.0987 | -0.00539 |
BT-20 | Palbociclib | 0.0031623 | CDK4/6 | Cell cycle | 0.9966 | 0.00011 |
BT-20 | Palbociclib | 0.31623 | CDK4/6 | Cell cycle | 0.2359 | 0.04751 |
BT-20 | AZD7762 | 1.0 | CHK1/2 | Cell cycle | 0.5068 | 0.21188 |
BT-20 | AZD7762 | 0.31623 | CHK1/2 | Cell cycle | 0.9454 | 0.07692 |